A research team at Kaiser Permanente found that good predictors of weight loss were the amount of sleep one got per night and stress levels experienced. They published their findings in March 2011 in the International Journal of Obesity.
Sleep, stress, television viewing, and computer screen time are factors that have been studied and associated with obesity but few have studied whether these factors correlated with weight loss.
About 500 subjects were asked to lose at least 10 pounds over six months and to report levels of insomnia, stress and depression, and to record how much time they slept and spent watching television or using a computer.
Each participant was weighed weekly, advised to keep a daily food diary, reduce caloric intake by 500 calories per day, eat a low-fat, low-sugar diet with lots of fruits and vegetables, and exercise at least 30 minutes, 6 times a week.
They found that those most likely to lose 10 pounds were those with the lowest stress levels and who got more than 6 hours, but less than 8 hours, of sleep per night. Also noted was that these subjects were twice as successful in losing weight as those who reported the highest stress levels and got less than 6 hours of sleep per night.
The research team found that sleep and stress levels were good predictors of weight loss, but depression and screen time were not.
This study suggests that if you want to increase your chances of losing weight reduce your stress level and get adequate sleep.
A survey conducted by McNeil Nutritionals, LLC with support of SHAPE magazine, determined that roughly more than a third of American women between the ages of 25-54 think about their weight at least three times a day, and many think that they need to implement very strict and drastic lifestyle changes in order to achieve their weight loss goals or maintain an ideal body weight.
It turns out it that a good place to start is by simply incorporating healthier habits into their daily routine. In other words, follow a calorically-appropriate diet, make smart substitutions with food choices, watch your portion sizes, and stay active.
The survey concluded that 70 percent of women currently add sugar to foods and beverages, for example, 48% of women admitted to adding sugar to their coffee. A simple solution to that is to replace 3 tablespoons of sugar each day with a “No Calorie Sweetener” such as SPLENDA, saving up to 100 calories!
Recently, a new implantable device known as IntraPace (also referred to as the Abiliti system), acquired CE Mark Certification, allowing for a commercialization strategy in Europe.
IntraPace is an implantable device that looks similar to a pacemaker, and is implanted via a simple minimally invasive surgical procedure. The Abiliti system sends low level electrical impulses to the stomach right when a person eats or drinks, helping a person feel full before the stomach is actually full, and causing them to eat or drink less. Clinical research with the Abiliti system has shown basically none of the nausea and other side effects seen with gastric bypass surgery and gastric banding, because the anatomy of the stomach is not changed. Instead of patients being restricted in the types of food that they consume, they are encouraged to implement a healthy diet and exercise program.
Also, this new system automatically records when a patient eats, drinks, and exercises. This allows for both patients and physicians to be able to view this data via a simple wireless connection. Benefits to this include being able to understand patient behaviors and develop effective strategies for weight loss. Another perk to the system is that it connects patients to a valuable social support network, which is believed to increase the effectiveness of any weight loss program.
Initially, the Abiliti system will be offered through specialist clinics, starting in the UK, Spain, and Germany.
Bariatric surgery is utilized for weight loss in people suffering from Morbid Obesity, but now Bariatric surgeons can also cure a common disease in obese patients…GERD (Gastroesophageal Reflux Disease)!
Transoral Incisionless Fundoplication (TIF) is a long-term incision-less procedure performed with an innovative FDA-approved EsophyX surgical device that corrects the deficiency at the gastroesophageal junction (also referred to as the “Z-line”), which causes heartburn and/or acid reflux, which are both common symptoms of GERD.
The procedure helps eliminate GERD by reconstructing a strong anti-reflux valve and tightening the Lower Esophageal Sphincter (LES), therefore reestablishing a barrier to reflux and restoring the competency of the gastroesophageal junction.
TIF is performed with the patient under general anesthesia, the procedure takes less than an hour and most patients go home the next day. The EsophyX device is inserted through the mouth and gently advanced into the esophagus under direct visualization of a video camera that is inserted down the central shaft of the device. The EsophyX device is then used to create and fasten several tissue folds, to create a strong anti-reflux valve at the gastroesophageal junction.
In the weeks following surgery, a natural healing process fuses and cements the tissue folds to create a robust anti-reflux barrier.
Recent studies conclude ALL patients discontinued their Proton Pump Inhibitors (PPIs) medication after the TIF procedure, and 79% remained completely off their daily medication two years after the procedure. Overall, patients reported 80% improvement in quality of life, with reduction/elimination of heartburn symptoms. Also, roughly 80% of patients experienced a reduction in their Hiatal Hernia, which is a defect in the diaphragm that allows the esophagus and top portion of the stomach to move from the abdominal cavity up into the chest cavity.
Overall, benefits of the TIF procedure performed with the EsophyX device allow for earlier and more effective intervention of GERD, thus minimizing the chances of developing malignant changes to the esophagus that may occur with long-standing GERD.
Are you having difficulty controlling your Diabetes Mellitus, Type II and lose weight? Now there is a revolutionary treatment for both that doesn’t require surgery or medication. It’s called the EndoBarrier Gastointestinal Liner.
The EndoBarrier is a flexible, thin, tube-shaped liner that fits inside a section of your intestine. It creates a barrier between your intestinal wall and the food you eat. The liner prevents food from coming into contact with the intestinal wall and delays digestion until farther down the intestine, both of which is believed to alter the activation of hormonal signals that originate in the intestine. Therefore, it changes the way your body responds to food and can drastically lower your glucose level, while also helping you lose weight.
The Endobarrier is inserted by a tube thru your mouth with no need for a surgical incision. A camera and x-ray equipment is used to best position the EndoBarrier. The EndoBarrier is secured just below your stomach (called the duodenal bulb) and extends approximately 60cm through portions of your intestine called the duodenum and the proximal jejunum. Once in place, the EndoBarrier starts to go to work immediately, by preventing the food you eat from coming into contact with normal digestive enzymes.
Placement of the EndoBarrier is performed in an outpatient setting, and when the time comes for removal, it can be retrieved via an endoscopic procedure without any permanent surgical consequences to your body.
Have you had an invasive weight loss surgery such as Gastric Bypass or Roux-En-Y to help treat your obesity? If so, have you been one of the many who have developed common complications from these procedures? If the answer is yes, then you may be very interested in this innovative procedure.
StomaphyX is an innovative FDA-approved single-use surgical device that can be used to create strong large tissue folds in the gastrointestinal tract, in order to achieve weight loss.
StomaphyX is performed under general anesthesia, the procedure takes approximately 30 minutes and most patients can return to their daily activities the next day or within a few days, on a soft liquid diet for roughly two weeks. StomaphyX is inserted through the mouth and is gently advanced into the stomach under direct visualization of the endoscopic camera. Once inside the stomach, the stomach wall is suctioned into the device’s tissue port creating a large tissue fold, and non-absorbable fasteners are then placed across the fold to hold the tissue in place.
StomaphyX has been proven to be safer than traditional invasive weight loss surgeries such as Gastric Bypass surgery or Roux en Y because it does not involve incisions on organs or on skin. The side effects have shown to be minimal or transient, and risks of incisional herniation, infection, adhesions or visible scarring have been proven to be reduced or eliminated. The StomaphyX procedure is mainly an attractive replacement for revisional surgery of invasive weight loss surgeries, which can be very dangerous.